99 related articles for article (PubMed ID: 33502888)
1. The role of subtotal and total gastrectomy in the treatment of gastric cancer.
Palaj J; Kečkéš Š; Waczulíková I; Marek V; Dyttert D; Sabol M; Durdík Š
Neoplasma; 2021 May; 68(3):621-625. PubMed ID: 33502888
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
Roukos D; Schmidt-Mathiesen A; Encke A
Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
[TBL] [Abstract][Full Text] [Related]
3. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery.
Roukos DH; Paraschou P; Lorenz M
Ann Surg Oncol; 2000 Dec; 7(10):719-26. PubMed ID: 11129418
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Lymph Node Metastasis Among Adults With Gastric Adenocarcinoma Managed With Total Gastrectomy.
Khalayleh H; Kim YW; Man Yoon H; Ryu KW; Kook MC
JAMA Netw Open; 2021 Feb; 4(2):e2035810. PubMed ID: 33566106
[TBL] [Abstract][Full Text] [Related]
5. Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
Ma F; Li Y; Li W; Kang W; Liu H; Ma S; Wang B; Xie Y; Zhong Y; Chen Y; Xue L; Tian Y
World J Surg Oncol; 2020 Feb; 18(1):43. PubMed ID: 32106866
[TBL] [Abstract][Full Text] [Related]
6. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.
Liu YY; Fang WL; Wang F; Hsu JT; Tsai CY; Liu KH; Yeh CN; Chen TC; Wu RC; Chiu CT; Yeh TS
Oncologist; 2017 Jan; 22(1):97-106. PubMed ID: 27789777
[TBL] [Abstract][Full Text] [Related]
7. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
[TBL] [Abstract][Full Text] [Related]
8. Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?
Lin JX; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M
Eur J Surg Oncol; 2017 Dec; 43(12):2357-2365. PubMed ID: 29032923
[TBL] [Abstract][Full Text] [Related]
9. Total gastrectomy for gastric cancer: 12-year data and review of the effect of performing lymphadenectomy.
Takeda J; Koufuji K; Kodama I; Tsuji Y; Yokoyama T; Kawabata S; Suematsu T; Kakegawa T
Kurume Med J; 1994; 41(1):15-21. PubMed ID: 7933913
[TBL] [Abstract][Full Text] [Related]
10. The survival of stage III gastric cancer patients is affected by the number of lymph nodes removed.
Liu KJ; Loewen M; Atten MJ; Millikan K; Tebbit C; Walter RJ
Surgery; 2003 Oct; 134(4):639-44; discussion 644-6. PubMed ID: 14605625
[TBL] [Abstract][Full Text] [Related]
11. Complications of gastrectomy with lymphadenectomy in gastric cancer.
Zilberstein B; Martins BC; Jacob CE; Bresciani C; Lopasso FP; de Cleva R; Pinto Junior PE; Junior UR; Perez RO; Gama-Rodrigues J
Gastric Cancer; 2004; 7(4):254-9. PubMed ID: 15616774
[TBL] [Abstract][Full Text] [Related]
12. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
15. Results of D2 gastrectomy for gastric cancer: lymph node chain dissection or multiple node resection?
Zilberstein B; Mucerino DR; Yagi OK; Ribeiro-Junior U; Lopasso FP; Bresciani C; Jacob CE; Coimbra BG; Cecconello I
Arq Bras Cir Dig; 2012; 25(3):161-4. PubMed ID: 23411804
[TBL] [Abstract][Full Text] [Related]
16. Total Versus Subtotal Gastrectomy for Distal Gastric Poorly Cohesive Carcinoma.
Boubaddi M; Teixeira Farinha H; Lambert C; Pereira B; Piessen G; Gualtierotti M; Voron T; Mantziari S; Pezet D; Gronnier C;
Ann Surg Oncol; 2024 Feb; 31(2):744-752. PubMed ID: 37971616
[TBL] [Abstract][Full Text] [Related]
17. Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life.
Davies J; Johnston D; Sue-Ling H; Young S; May J; Griffith J; Miller G; Martin I
World J Surg; 1998 Oct; 22(10):1048-55. PubMed ID: 9747165
[TBL] [Abstract][Full Text] [Related]
18. Total and Subtotal Laparoscopic Gastrectomy for the Treatment of Advanced Gastric Cancer: Morbidity and Oncological Outcomes.
Olmi S; Giorgi R; Cioffi SPB; Uccelli M; Villa R; Ciccarese F; Scotto B; Castello G; Legnani G; Cesana G
J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):278-285. PubMed ID: 29135363
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
[TBL] [Abstract][Full Text] [Related]
20. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
